— Know what they know.
Not Investment Advice

Financial News

Sentiment -83.4 2212 articles 899 bullish 663 bearish Full Index →
Caterpillar Climbs Above 50-Day SMA: Time to Buy the Stock?

Caterpillar Climbs Above 50-Day SMA: Time to Buy the Stock?

CAT breaks above its 50-day SMA as record revenues, rising estimates and strong backlog fuel optimism despite tariff-driven margin pressure.
Airline Stocks Soar: United, American Take Off On War De-Esc

Airline Stocks Soar: United, American Take Off On War De-Escalation Hopes

Airline stocks are taking flight this Wednesday. United Airlines Holdings Inc. (NASDAQ:UAL) and American Airlines Group Inc. (NASDAQ:AAL) saw...
Airline Stocks Soar: United, American Take Off On War De-Esc

Airline Stocks Soar: United, American Take Off On War De-Escalation Hopes

Airline stocks are taking flight this Wednesday. United Airlines Holdings Inc. (NASDAQ:UAL) and American Airlines Group Inc. (NASDAQ:AAL) saw...
📰

Where Will Nu Holdings Stock Be in 10 Years?

The Latin American fintech stock has plenty of upside.
📰

Can Super Mario Save Nintendo Stock, Again?

The gaming giant has had a rough few months, but its biggest star is on the biggest screen again.
📰

Can Super Mario Save Nintendo Stock, Again?

The gaming giant has had a rough few months, but its biggest star is on the biggest screen again.
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1 Foundayo, Lilly's second FDA-approved obesity...
Prefilled Syringes Market worth $14.53 billion by 2031 | Mar

Prefilled Syringes Market worth $14.53 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., April 1, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Prefilled Syringes Market is projected to grow from about USD...
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1 Foundayo, Lilly's second FDA-approved obesity...
📰

Here's How Much You Would Have Made Owning Fidelity MSCI Energy Index ETF Stock In The Last 5 Years

Fidelity MSCI Energy Index ETF (NYSE:FENY) has outperformed the market over the past 5 years by 9.82% on an annualized basis producing an average...
Can Visa's Ramp Integration Transform Enterprise Spend Manag

Can Visa's Ramp Integration Transform Enterprise Spend Management?

V deepens Ramp tie-up to embed AI-driven automation into enterprise spend, aiming to evolve from payments processor to finance infrastructure layer.
Can Visa's Ramp Integration Transform Enterprise Spend Manag

Can Visa's Ramp Integration Transform Enterprise Spend Management?

V deepens Ramp tie-up to embed AI-driven automation into enterprise spend, aiming to evolve from payments processor to finance infrastructure layer.
Can Visa's Ramp Integration Transform Enterprise Spend Manag

Can Visa's Ramp Integration Transform Enterprise Spend Management?

V deepens Ramp tie-up to embed AI-driven automation into enterprise spend, aiming to evolve from payments processor to finance infrastructure layer.
Can Visa's Ramp Integration Transform Enterprise Spend Manag

Can Visa's Ramp Integration Transform Enterprise Spend Management?

V deepens Ramp tie-up to embed AI-driven automation into enterprise spend, aiming to evolve from payments processor to finance infrastructure layer.
Can Visa's Ramp Integration Transform Enterprise Spend Manag

Can Visa's Ramp Integration Transform Enterprise Spend Management?

V deepens Ramp tie-up to embed AI-driven automation into enterprise spend, aiming to evolve from payments processor to finance infrastructure layer.
Can Visa's Ramp Integration Transform Enterprise Spend Manag

Can Visa's Ramp Integration Transform Enterprise Spend Management?

V deepens Ramp tie-up to embed AI-driven automation into enterprise spend, aiming to evolve from payments processor to finance infrastructure layer.
📰

This Red-Hot Sector of the Crypto Market Isn't Slowing Down Anytime Soon

Top artificial intelligence (AI) cryptos are up as much as 45% to start the year.
📰

This Red-Hot Sector of the Crypto Market Isn't Slowing Down Anytime Soon

Top artificial intelligence (AI) cryptos are up as much as 45% to start the year.
📰

Conrad GAAP EPS of $3.96

Nvidia vs Broadcom: Which AI Stock Will Make You More Money

Nvidia vs Broadcom: Which AI Stock Will Make You More Money

Tech giant Nvidia (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) both just reported blockbuster AI-driven quarters. Nvidia posted Q4 revenue of $68.13...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
FBLG: Advancing Fibroblast Therapy on Multiple Fronts

FBLG: Advancing Fibroblast Therapy on Multiple Fronts

By David Bautz, PhD NASDAQ: FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Advancing Fibroblast Therapy on Multiple Fronts In the past...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
Here's Why You Should Retain IRTC Stock in Your Portfolio fo

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the...
Axe Compute (AGPU) Stock Soars After Executed GPU Agreements

Axe Compute (AGPU) Stock Soars After Executed GPU Agreements

Axe Compute Inc (NASDAQ:AGPU) shares are trading sharply higher Wednesday morning after the company said it signed about $12 million in total...
Retirement Portfolios May Expand To Include Crypto Under New

Retirement Portfolios May Expand To Include Crypto Under New US Rule

A new U.S. Labor Department rule could allow 401(k) retirement plans to include alternative investments such as cryptocurrencies, real estate and...
Eli Lilly stock surges after FDA approves obesity pill

Eli Lilly stock surges after FDA approves obesity pill

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wi

BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod

Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, informed decisions...
« Prev 1 139 140 141 142 143 448 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms